SCHEMBL8306282

SCHEMBL8306282

CC(=NO)c1ccc(-c2ccc(C)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 6/20 0.51
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 2/20 0.41
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
MAPK1 P28482 1/20 0.41
STAT3 P40763 1/20 0.41
STAT1 P42224 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
POLB P06746 1/20 0.40
CASP3 P42574 1/20 0.40
GFER P55789 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
ESR1 P03372 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12741076 0.93 CA9 (0.56) CA9ALDH1A1LMNACES2CES1
SCHEMBL514858 0.93 CA9 (0.56) CA9ALDH1A1LMNACES2CES1
SCHEMBL514859 0.93 CA9 (0.56) CA9ALDH1A1LMNACES2CES1
SCHEMBL28264695 0.91 CA9 (0.54) CA9ALDH1A1LMNACES2CES1
SCHEMBL13645704 0.91 CA9 (0.47) CA9ALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL14298196 0.83 CA9 (0.52) CA9ALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL12360950 0.83 CA9 (0.52) CA9ALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL4316450 0.82 SMN1; SMN2 (0.56) CA9ALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL3368876 0.82 SMN1; SMN2 (0.56) CA9ALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL5609938 0.80 LMNA (0.50) CA9ALDH1A1LMNACES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed